Oral salmon calcitonin: Completed Phase III enrollment

Novartis and Nordic completed enrollment of >1,100 patients ages 51-80 years in a double-blind, placebo-controlled, international Phase III trial evaluating oral SMC021. In 2000, Emisphere granted exc...